Dasher David A, Burkhart Craig N, Morrell Dean S
Department of Dermatology, UNC Chapel Hill, USA.
Pediatr Ann. 2009 Jul;38(7):373-9. doi: 10.3928/00904481-20090622-06.
Treatment-resistant warts are a common and frustrating problem for patients, parents, and providers alike. No wart treatment is uniformly effective. Indeed, well-designed randomized controlled trials are sorely needed to establish the true efficacy of all wart therapies. Treatment should be tailored to each individual patient. Although none of the immunologically-based treatments listed above (see Table, page 377) is FDA-approved for warts, they provide the treating physician with options for patients with warts that are resistant to standard treatments.
难治性疣对患者、家长和医疗服务提供者来说都是一个常见且令人沮丧的问题。没有一种疣治疗方法是完全有效的。事实上，非常需要精心设计的随机对照试验来确定所有疣治疗方法的真正疗效。治疗应根据每个患者的情况量身定制。尽管上述基于免疫的治疗方法（见表，第377页）均未获得美国食品药品监督管理局（FDA）批准用于治疗疣，但它们为治疗医生提供了针对对标准治疗有抗性的疣患者的选择。
